research use only

Fenoldopam Dopamine Receptor agonist

Cat.No.S2089

Fenoldopam (SKF 82526) is a selective dopamine-1 (DA1) receptor agonist with natriuretic/diuretic properties with EC50 of 55.5 nM in stimulating cAMP accumulation in LLC-PK1 cells, which is more potent than DA .
Fenoldopam Dopamine Receptor agonist Chemical Structure

Chemical Structure

Molecular Weight: 305.76

Jump to

Quality Control

Batch: S208901 DMSO]77 mg/mL]false]Water]10 mg/mL]false]Ethanol]Insoluble]false Purity: 99.70%
  • Cited in Nature Medicine for its top-tier quality
  • COA
  • NMR
  • HPLC
  • SDS
  • Datasheet
99.70

Solubility

In vitro
Batch:

DMSO : 77 mg/mL (251.83 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 10 mg/mL

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 305.76 Formula

C16H16ClNO3

Storage (From the date of receipt)
CAS No. 67227-56-9 Download SDF Storage of Stock Solutions

Synonyms SKF 82526 Smiles OC1=CC=C(C=C1)C2CNCCC3=C(Cl)C(=C(O)C=C23)O

Mechanism of Action

Targets/IC50/Ki
DA1 receptor
55.5 nM(EC50)
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02620761 Terminated
Patent Ductus Arteriosus (PDA)|Acute Kidney Injury (AKI)
Medical College of Wisconsin
February 6 2019 Phase 2|Phase 3
NCT00592150 Unknown status
Hypertension
University of Virginia|National Institutes of Health (NIH)
June 2007 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map